EphA2 could activate Wnt/beta‐catenin and Hippo signalling pathways, which in turn induced EMT and downstream signalling cascade, thus mediating tumour invasiveness and resistance to cancer therapeutics in gastric cancer.8, 11. This evidence concerns the gene CTNNB1 and cancer.